Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Patient-specific simulation of transcatheter aortic valve replacement: impact of deployment options on paravalvular leakage.

Bianchi M, Marom G, Ghosh RP, Rotman OM, Parikh P, Gruberg L, Bluestein D.

Biomech Model Mechanobiol. 2019 Apr;18(2):435-451. doi: 10.1007/s10237-018-1094-8. Epub 2018 Nov 20.

PMID:
30460623
2.

Impact of prior revascularization on the outcomes of patients presenting with ST-elevation myocardial infarction and cardiogenic shock.

Singh P, Lima FV, Parikh P, Zhu C, Lawson W, Mani A, Jeremias A, Yang J, Gruberg L.

Cardiovasc Revasc Med. 2018 Dec;19(8):923-928. doi: 10.1016/j.carrev.2018.10.013. Epub 2018 Oct 15.

PMID:
30344055
3.

Simultaneous thoracic aortic endovascular graft and transfemoral transcatheter aortic valve replacement in a patient with a descending aortic thrombus.

Parikh PB, Loh S, Gruberg L, Weinstein J, Tannous H, Bilfinger T.

Cardiovasc Revasc Med. 2019 Jan;20(1):87-88. doi: 10.1016/j.carrev.2018.08.012. Epub 2018 Aug 16.

PMID:
30170829
4.

Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Lima FV, Singh S, Parikh PB, Gruberg L.

Cardiovasc Revasc Med. 2018 Sep;19(6S):16-20. doi: 10.1016/j.carrev.2018.06.002. Epub 2018 Jun 9.

PMID:
29929842
5.

Realistic Vascular Replicator for TAVR Procedures.

Rotman OM, Kovarovic B, Sadasivan C, Gruberg L, Lieber BB, Bluestein D.

Cardiovasc Eng Technol. 2018 Sep;9(3):339-350. doi: 10.1007/s13239-018-0356-z. Epub 2018 Apr 13.

PMID:
29654509
6.

Transcarotid Transcatheter Aortic Valve Replacement as Preferred Alternative Access in a Patient With Bilateral Carotid Artery Disease.

Parikh PB, Loh S, Gruberg L, Patel N, Weinstein J, Tannous H, Bilfinger T.

J Invasive Cardiol. 2018 Jan;30(1):E9-E10.

7.

Impact of atrial fibrillation in patients with chronic kidney disease undergoing transcatheter aortic valve replacement: Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample.

Cheung A, Lima FV, Yen TYM, Parikh P, Butler J, Gruberg L.

Cardiovasc Revasc Med. 2018 Jan;19(1 Pt A):21-25. doi: 10.1016/j.carrev.2017.06.012. Epub 2017 Jul 1.

PMID:
29276175
8.

Impact of chronic kidney disease on mortality in adults undergoing balloon aortic valvuloplasty.

Parikh PB, Novotny S, Jeremias A, Butler J, Yang J, Yin D, Gruberg L.

Cardiovasc Revasc Med. 2018 Jun;19(4):448-451. doi: 10.1016/j.carrev.2017.10.012. Epub 2017 Oct 26.

PMID:
29223500
9.

The impact of unfractionated heparin or bivalirudin on patients with stable coronary artery disease undergoing percutaneous coronary intervention.

Lima FV, Gruberg L, Aslam U, Ramgadoo M, Clase K, Trevisan A, Jeremias A.

J Interv Cardiol. 2018 Apr;31(2):177-184. doi: 10.1111/joic.12462. Epub 2017 Dec 4.

PMID:
29205487
10.

Here we go Again: Trying to prevent contrast-induced nephropathy.

Lima FV, Gruberg L.

Cardiovasc Revasc Med. 2017 Jul - Aug;18(5):313-314. doi: 10.1016/j.carrev.2017.05.020. Epub 2017 May 31. No abstract available.

PMID:
28602575
11.

Relation of Body Mass Index and Gender to Left Atrial Size and Atrial Fibrillation.

Huang G, Parikh PB, Malhotra A, Gruberg L, Kort S.

Am J Cardiol. 2017 Jul 15;120(2):218-222. doi: 10.1016/j.amjcard.2017.04.013. Epub 2017 Apr 27.

PMID:
28583686
12.

Impact of chronic kidney disease in patients undergoing percutaneous or surgical carotid artery revascularization: Insights of the healthcare cost and utilization Project's National Inpatient Sample.

Lima FV, Yen TY, Butler J, Yang J, Xu J, Gruberg L.

Cardiovasc Revasc Med. 2016 Dec;17(8):560-565. doi: 10.1016/j.carrev.2016.08.014. Epub 2016 Sep 7.

PMID:
27988086
13.

Causes of Elevated Cardiac Troponins in the Emergency Department and Their Associated Mortality.

Meigher S, Thode HC, Peacock WF, Bock JL, Gruberg L, Singer AJ.

Acad Emerg Med. 2016 Nov;23(11):1267-1273. doi: 10.1111/acem.13033. Epub 2016 Nov 3.

14.

The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry.

Gruberg L, Hellkamp AS, Thomas LE, de Lemos JA, Scirica BM, Hilliard A, Enriquez JR, Mohsen A, Wang TY.

JACC Cardiovasc Interv. 2015 Dec 28;8(15):1954-1962. doi: 10.1016/j.jcin.2015.08.030.

15.

Percutaneous Mechanical Support in Cardiogenic Shock: A Review.

Gilani FS, Farooqui S, Doddamani R, Gruberg L.

Clin Med Insights Cardiol. 2015 May 28;9(Suppl 2):23-8. doi: 10.4137/CMC.S19707. eCollection 2015. Review.

16.

Bare metal stents: I am still standing.

Gruberg L.

Cardiovasc Revasc Med. 2015 Mar;16(2):63-4. doi: 10.1016/j.carrev.2015.02.006. No abstract available.

PMID:
25870150
17.

Association of elevated radiation dose with mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Parikh PB, Prakash S, Tahir U, Kort S, Gruberg L, Jeremias A.

Cardiovasc Revasc Med. 2014 Sep-Oct;15(6-7):340-5. doi: 10.1016/j.carrev.2014.07.005. Epub 2014 Jul 31.

PMID:
25165016
18.

Informed consent for cardiac procedures: deficiencies in patient comprehension with current methods.

Dathatri S, Gruberg L, Anand J, Romeiser J, Sharma S, Finnin E, Shroyer AL, Rosengart TK.

Ann Thorac Surg. 2014 May;97(5):1505-11; discussion 1511-2. doi: 10.1016/j.athoracsur.2013.12.065. Epub 2014 Mar 12.

PMID:
24629303
19.

Coil embolization of an aortic pseudoaneurysm after open repair of type A aortic dissection.

Jain V, Gruberg L, Bilfinger TV, Tassiopoulos AK, Loh SA.

Ann Vasc Surg. 2014 Jul;28(5):1312.e1-5. doi: 10.1016/j.avsg.2013.12.032. Epub 2014 Feb 8.

PMID:
24517983
20.

Clinical outcomes in real-world patients with small vessel disease treated with XIENCE V® everolimus-eluting stents: one year results from the XIENCE V® USA condition of approval post-market study.

Hermiller JB, Rutledge DR, Mao VW, Zhao W, Wang J, Gruberg L, Lombardi W, Sharma SK, Krucoff MW.

Catheter Cardiovasc Interv. 2014 Jul 1;84(1):7-16. doi: 10.1002/ccd.25325. Epub 2014 Jan 13.

PMID:
24327421
21.

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data.

Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, White HD, Harrington RA; CHAMPION Investigators.

Lancet. 2013 Dec 14;382(9909):1981-92. doi: 10.1016/S0140-6736(13)61615-3. Epub 2013 Sep 3.

PMID:
24011551
22.

Impact of glomerular filtration rate on clinical outcomes after carotid artery revascularization in 11,832 patients from the CARE registry.

Gruberg L, Jeremias A, Rundback JH, Anderson HV, Spertus JA, Kennedy KF, Rosenfield KA.

Catheter Cardiovasc Interv. 2014 Aug 1;84(2):246-54. doi: 10.1002/ccd.25101. Epub 2014 May 3.

PMID:
23813603
23.

The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.

Bench TJ, Parikh PB, Jeremias A, Brener SJ, Naidu SS, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

J Invasive Cardiol. 2013 Apr;25(4):166-9.

24.

Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

J Invasive Cardiol. 2013 Mar;25(3):114-7.

25.

Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial.

Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Todd M, Bhatt DL, Stone GW, Lincoff AM, Dauerman HL, Gibson CM, White HD, Parikh KH, Gruberg L, Herrmann HC, McLaurin BT, Goodman SG, Mahaffey KW.

Coron Artery Dis. 2013 Jun;24(4):321-7. doi: 10.1097/MCA.0b013e32835f2fbd.

PMID:
23442944
26.

Biomechanical factors in coronary vulnerable plaque risk of rupture: intravascular ultrasound-based patient-specific fluid-structure interaction studies.

Liang X, Xenos M, Alemu Y, Rambhia SH, Lavi I, Kornowski R, Gruberg L, Fuchs S, Einav S, Bluestein D.

Coron Artery Dis. 2013 Mar;24(2):75-87. doi: 10.1097/MCA.0b013e32835bbe99.

PMID:
23363983
27.

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).

Waksman R, Bertrand O, Driesman M, Gruberg L, Rossi J, Mehta S, Swymelar S, Dvir D, Xue Z, Torguson R.

J Interv Cardiol. 2013 Apr;26(2):107-13. doi: 10.1111/joic.12005. Epub 2012 Dec 13.

PMID:
23240743
28.

Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study.

Hermiller JB, Rutledge DR, Gruberg L, Katopodis JN, Lombardi W, Mao VW, Zhao W, Sharma SK, Tamboli HP, Wang J, Jonnavithula L, Sudhir K, Krucoff MW.

J Interv Cardiol. 2012 Dec;25(6):565-75. doi: 10.1111/j.1540-8183.2012.00766.x. Epub 2012 Sep 23.

PMID:
22998355
29.

Forget Mars and venus, men and women are from the same planet after all.

Parikh PB, Gruberg L.

J Invasive Cardiol. 2012 Jun;24(6):261-2. Review. No abstract available.

30.

Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.

PMID:
22566286
31.

Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.

White HD, Chew DP, Dauerman HL, Mahaffey KW, Gibson CM, Stone GW, Gruberg L, Harrington RA, Bhatt DL.

Am Heart J. 2012 Feb;163(2):182-90.e4. doi: 10.1016/j.ahj.2011.11.001.

PMID:
22305835
32.

A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study).

Krucoff MW, Rutledge DR, Gruberg L, Jonnavithula L, Katopodis JN, Lombardi W, Mao VW, Sharma SK, Simonton CA, Tamboli HP, Wang J, Wilburn O, Zhao W, Sudhir K, Hermiller JB.

JACC Cardiovasc Interv. 2011 Dec;4(12):1298-309. doi: 10.1016/j.jcin.2011.08.010.

33.

Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial).

Skolnick AH, Reynolds HR, White HD, Menon V, Carvalho AC, Maggioni AP, Pearte CA, Gruberg L, Azevedo RE, Schroeder E, Forman SA, Lamas GA, Hochman JS, Džavík V.

Am J Cardiol. 2012 Mar 1;109(5):614-9. doi: 10.1016/j.amjcard.2011.10.015. Epub 2011 Dec 14.

34.

Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention.

Parikh PB, Gruberg L, Jeremias A, Chen JJ, Naidu SS, Shlofmitz RA, Brener SJ, Pappas T, Marzo KP, Brown DL.

Am Heart J. 2011 Sep;162(3):512-7. doi: 10.1016/j.ahj.2011.06.002. Epub 2011 Jul 26.

PMID:
21884869
35.

Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.

Najjar SS, Rao SV, Melloni C, Raman SV, Povsic TJ, Melton L, Barsness GW, Prather K, Heitner JF, Kilaru R, Gruberg L, Hasselblad V, Greenbaum AB, Patel M, Kim RJ, Talan M, Ferrucci L, Longo DL, Lakatta EG, Harrington RA; REVEAL Investigators.

JAMA. 2011 May 11;305(18):1863-72. doi: 10.1001/jama.2011.592.

36.

Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

Am J Cardiol. 2011 May 1;107(9):1319-23. doi: 10.1016/j.amjcard.2010.12.042. Epub 2011 Feb 23.

PMID:
21349486
37.

Resolute™ drug-eluting stent: a resolution for bifurcation lesions?

Jermyn R, Gruberg L.

J Invasive Cardiol. 2011 Feb;23(2):54-5. No abstract available.

38.

Preventing the unpreventable? Rotational angiography for the prevention of contrast-induced nephropathy.

Menon D, Gruberg L.

J Invasive Cardiol. 2010 Sep;22(9):432-3. No abstract available.

39.

Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction.

Jeremias A, Gruberg L, Patel J, Connors G, Brown DL.

Am J Cardiol. 2010 May 1;105(9):1268-71. doi: 10.1016/j.amjcard.2009.12.043. Epub 2010 Mar 11.

PMID:
20403477
40.

Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting.

Jeremias A, Vasu S, Gruberg L, Kastrati A, Stone GW, Brown DL.

Catheter Cardiovasc Interv. 2010 May 1;75(6):895-902. doi: 10.1002/ccd.22349.

PMID:
20088008
41.

Renal insufficiency and prognosis after primary PCI: still bad after all these years.

Gruberg L.

J Invasive Cardiol. 2009 Oct;21(10):499-500. No abstract available.

PMID:
19805834
42.

A mechanical approach to limit contrast-induced nephropathy: sentinel at the gate.

Gruberg L, Jeremias A.

J Invasive Cardiol. 2009 Jul;21(7):319-20. No abstract available.

PMID:
19571340
43.

Provisional use of glycoprotein IIb/IIIa inhibitors in the era of dual antiplatelet therapy--do "bailouts" pay off?

Jeremias A, Gruberg L.

J Invasive Cardiol. 2009 Jun;21(6):264-5. No abstract available.

PMID:
19494401
44.

The impact of revascularization on mortality in patients with nonacute coronary artery disease.

Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL.

Am J Med. 2009 Feb;122(2):152-61. doi: 10.1016/j.amjmed.2008.07.027.

PMID:
19185092
45.

Troponin-positive, CK-MB-negative acute myocardial infarction: clinical, electrocardiographic and angiographic characteristics.

Gruberg L, Sudarsky D, Kerner A, Hammerman H, Kapeliovich M, Beyar R.

J Invasive Cardiol. 2008 Mar;20(3):125-8.

46.

Angiographically uncertain left main coronary artery narrowings: correlation with multidetector computed tomography and intravascular ultrasound.

Dragu R, Kerner A, Gruberg L, Rispler S, Lessick J, Ghersin E, Litmanovich D, Engel A, Beyar R, Roguin A.

Int J Cardiovasc Imaging. 2008 Jun;24(5):557-63. doi: 10.1007/s10554-007-9290-0. Epub 2007 Dec 30.

PMID:
18165931
47.
48.
49.

TCD evaluation before and after stenting in patients with severe primary carotid artery stenosis versus restenosis.

Telman G, Kouperberg E, Sprecher E, Gruberg L, Beyar R, Yarnitsky D.

J Endovasc Ther. 2007 Aug;14(4):483-8.

PMID:
17696622
50.

Safety and efficacy of the FilterWire EZ in acute ST-segment elevation myocardial infarction.

Guetta V, Mosseri M, Shechter M, Matetzky S, Assali A, Almagor Y, Gruberg L, Benderly M, Lotam C, Kornowski R; UpFlow MI Study Investigators.

Am J Cardiol. 2007 Apr 1;99(7):911-5. Epub 2007 Feb 12.

PMID:
17398182

Supplemental Content

Loading ...
Support Center